{
  "chapter": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea",
  "questions": [
    {
      "q_no": 1,
      "question": "A 16-year-old female with cystic fibrosis presents with increased productive cough, fever, and worsening shortness of breath. Her sputum culture grows Pseudomonas aeruginosa. Which of the following best explains why this organism commonly causes respiratory infections in cystic fibrosis patients?",
      "options": {
        "A": "Defective neutrophil chemotaxis to the site of infection",
        "B": "Abnormal periciliary fluid layer leading to impaired mucociliary clearance",
        "C": "Direct immunosuppressive effect of the CFTR protein mutation",
        "D": "Increased expression of bacterial adhesion molecules on respiratory epithelium"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Abnormal periciliary fluid layer leading to impaired mucociliary clearance results in abnormal ion transport across epithelial surfaces. This causes depletion of the periciliary fluid layer (PCL). The abnormal PCL prevents proper ciliary function and mucus clearance, creating an environment where bacteria like P. aeruginosa can thrive and establish chronic infections. Pathogenesis of Cystic Fibrosis Mechanism Key Features CFTR Defect Defective chloride/bicarbonate transport Located in apical plasma membranes F508del (phenylalanine is replaced) mutation most common (~70%) Airway Changes Depleted periciliary fluid layer Thick mucus accumulation Impaired mucociliary clearance Infection Risk Common pathogens: P. aeruginosa, S. aureus Chronic bacterial colonization Progressive bronchiectasis Clinical Impact Recurrent pneumonia Progressive lung damage Requires aggressive antibiotic therapy Neutrophil chemotaxis is not defective in CF. In fact, there is an aggressive neutrophilic inflammatory response in CF airways ( Option A) CFTR mutations don't cause immunosuppression. The immune system remains active and responsive, with ongoing innate and adaptive immune reactivity ( Option C) While bacterial adhesion may occur, the primary pathogenic mechanism is the mechanical failure of mucus clearance due to abnormal PCL, not increased adhesion molecules ( Option D) Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Volume I, Page. 2176, 2177",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 2,
      "question": "A 3-month-old infant presents with failure to thrive, recurrent respiratory infections, and elevated sweat chloride. Genetic testing reveals two copies of the F508del mutation in the CFTR gene. This mutation results in a protein that fails to reach the cell surface due to degradation in the endoplasmic reticulum. Which class of CFTR mutation does this represent, and what percentage of CF patients carry at least one copy of this mutation?",
      "options": {
        "A": "Class I mutation; ~30% of patients",
        "B": "Class II mutation; ~70% of patients",
        "C": "Class III mutation; ~50% of patients",
        "D": "Class IV mutation; ~40% of patients"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Class II mutation; ~70% of patients Explanation: F508del is a Class II CFTR mutation characterized by protein processing defects. It is the most common mutation class in Cystic fibrosis , with 70% of CF patients carrying at least one copy of the F508del mutation Genetic basis of CFTR Mutation- Cystic Fibrosis Mutation Class Severity Protein Effect Clinical Impact Class I & II (Option A) Severe No functional protein or severe processing defect Pancreatic insufficiency, severe lung disease Class III & IV (Option C, D) Moderate Defective channel function or conductance Variable pancreatic status, moderate lung disease Class V Mild to Moderate Reduced amount of normal protein Lower incidence of pancreatic insufficiency compared to class I and II, milder lung disease Class VI Variable Decreased protein stability Variable severity based on protein turnover rate Pathological features of Cystic Fibrosis Organ System Pathological Features Clinical Manifestations Diagnostic Findings Respiratory Thick mucus plugging Bronchiectasis Chronic inflammation Submucosal gland hypertrophy Chronic productive cough Recurrent infections Progressive dyspnea Digital clubbing P. aeruginosa in sputum Obstructive pattern on PFTs Bronchiectasis on CT Pancreatic Duct obstruction Acinar cell destruction Fibrosis Fat replacement Malabsorption Steatorrhea Failure to thrive Fat-soluble vitamin deficiency Low fecal elastase Elevated fecal fat Low vitamins A, D, E, K Sweat Glands Abnormal chloride transport Normal gland structure Salty-tasting skin Heat intolerance Salt depletion Elevated sweat chloride >60 mEq/L diagnostic Hepatobiliary Bile duct plugging Focal biliary cirrhosis Multilobular cirrhosis Neonatal cholestasis Portal hypertension Gallstones Elevated liver enzymes Ultrasound changes Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Volume I, Page. 2176, 2177",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 3,
      "question": "A 3-year-old boy comes to the emergency department with difficulty breathing and a productive cough. He has a history of recurrent sinusitis and otitis media and usually responds well to antibiotics. Crackles and wheezing are heard on pulmonary auscultation and CVS examination shows the cardiac point of maximum impulse on the right 5th intercostal space. Which of them is not seen in this condition?",
      "options": {
        "A": "Dynein arm defect",
        "B": "Normal sweat chloride test",
        "C": "CFTR mutation",
        "D": "Defective mucociliary clearance"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) CFTR mutation Explanation: Kartagener’s Syndrome vs Cystic Fibrosis Features Kartagener's Syndrome Cystic Fibrosis Diagnostic Triad Situs inversus Recurrent sinusitis Recurrent pneumonia Chronic cough Steatorrhea Failure to thrive Molecular Defect Dynein protein defect (Option A) CFTR mutation Primary Problem Defective mucociliary clearance (Option D) Abnormal chloride transport Key Features Male infertility Situs inversus Normal sweat chloride (Option B) Elevated sweat chloride Male and female infertility Pancreatic insufficiency Normal organ placement Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Volume I, Page. 2176, 2177 Lung India- Uptodate",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 4,
      "question": "A 7-year-old child presents with a chronic productive cough, nasal polyps, and poor weight gain despite normal appetite. Which of the following is the most likely associated condition?",
      "options": {
        "A": "Primary ciliary dyskinesia",
        "B": "Asthma",
        "C": "Cystic fibrosis",
        "D": "Bronchopulmonary dysplasia"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Cystic fibrosis Explanation: Cystic fibrosis is characterized by respiratory complications, such as chronic cough due to thick mucus, and growth impairment due to pancreatic insufficiency. Nasal polyps are also commonly associated with CF I . Clinical Features of Cystic Fibrosis: Cystic fibrosis (CF) is a multisystem genetic disorder primarily affecting the respiratory and digestive systems, caused by mutations in the CFTR gene. System Manifestations Respiratory System: Due to defective chloride channels, airway mucus becomes dehydrated and highly viscous. Airway Obstruction: Thickened mucus obstructs the airways, making it difficult to clear, trapping pathogens, and leading to frequent infections. Chronic Infections: CF patients harbour chronic infections with Staphylococcus aureus, Haemophilus influenzae, and Pseudomonas aeruginosa. Over time, Pseudomonas evolves into a mucoid form that is highly resistant to treatment and worsens prognosis. Inflammation and Bronchiectasis: Persistent infection leads to chronic neutrophilic inflammation, damaging airway tissue and causing bronchiectasis (permanent airway dilation). This inflammatory response further exacerbates mucus accumulation and infection. Pancreas: CFTR dysfunction leads to blockage of pancreatic ducts by thickened secretions. Exocrine Pancreatic Insufficiency: The ducts become obstructed, preventing digestive enzymes from reaching the intestines, leading to malabsorption, steatorrhea (fatty stools), and poor weight gain . Endocrine Dysfunction: Over time, recurrent inflammation and fibrosis damage pancreatic islets, increasing the risk of CF-related diabetes mellitus (CFRD) , a common complication in adults with CF. Gastrointestinal Tract: Thick mucus impacts various parts of the gastrointestinal system. Meconium Ileus in Newborns: Nearly 10-20% of newborns with CF present with meconium ileus, an intestinal obstruction that can be life-threatening without surgical intervention. Distal Intestinal Obstructive Syndrome (DIOS): Older children and adults may experience DIOS, where thickened intestinal contents obstruct the lower intestines. Liver CF can lead to biliary cirrhosis due to mucus plugging in bile ducts. Approximately 5-10% of patients develop multilobular cirrhosis, which may progress to portal hypertension and liver failure . Reproductive System Male Infertility: Males with CF will have a congenital bilateral absence of the vas deferens (CBAVD) , leading to infertility despite normal spermatogenesis . Female Infertility: Females with CF may also face reduced fertility due to thick cervical mucus that hinders sperm penetration. Other common manifestations include chronic sinusitis, nasal polyps, digital clubbing, and reduced bone mineral density. Primary ciliary dyskinesia may present similarly but is less commonly associated with nasal polyps. (Option A) Asthma does not typically cause poor weight gain because it commonly only affects the respiratory system. (Option B) Bronchopulmonary dysplasia (BPD) is a chronic lung disease that primarily affects premature infants who have received prolonged mechanical ventilation and oxygen therapy in the neonatal period. It is characterized by abnormal development of the lungs, resulting in long-term respiratory problems.. (Option D) Reference: Harrison’s Principles Of Internal Medicine, 21st Edition, Volume I, Page 2202, 2203",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 5,
      "question": "A 2-month-old infant presents with recurrent respiratory infections and failure to thrive. Physical examination reveals digital clubbing and productive cough. A sweat test shows elevated chloride levels, but the genotype analysis for common CFTR mutations is inconclusive. Which of the following investigations is the next best step for confirming the diagnosis of cystic fibrosis in this patient?",
      "options": {
        "A": "Bronchoalveolar lavage",
        "B": "Nasal potential difference measurement",
        "C": "Chest X-ray",
        "D": "Genetic panel including rare CFTR mutations"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Nasal potential difference measurement Explanation: Cystic fibrosis (CF) is primarily diagnosed through a combination of clinical presentation, sweat chloride testing, genetic testing, and other tests such as nasal potential difference measurement. Diagnostic Criteria for Cystic Fibrosis (CF): Presence of one or more phenotypic features (or) A history of Cystic Fibrosis in a sibling (or) A positive neonatal screening test - Dried blood is checked for immunoreactive trypsinogen. PLUS Laboratory evidence for CFTR (Cystic Fibrosis transmembrane regulator) dysfunction: Two elevated sweat chloride concentrations (highly specific test) obtained at separate labs > 60 mEq/L (or) Identification of two Cystic Fibrosis mutations by DNA sequencing (or) An abnormal transepithelial nasal potential difference measurement Investigations: Sweat Chloride Test: The gold standard for CF diagnosis, especially in symptomatic patients. Pilocarpine iontophoresis is used to stimulate sweat production, and chloride concentration is measured. A chloride concentration of: ≥ 60 mmol/L confirms CF in children and adults. 30-59 mmol/L indicates intermediate results, requiring further evaluation. In CF- sweat chloride levels are increased while chloride levels are decreased in pancreatic secretions Genetic Testing: Genetic testing, particularly for the common F508del mutation, is conducted if CF is suspected. Expanded genetic panels may include hundreds of mutations but are often limited in efficacy for rare variants. Nasal Potential Difference (NPD): This test measures the bioelectric properties of the respiratory epithelium, reflecting CFTR function. In CF, defective chloride and sodium transport leads to abnormal potential differences. NPD testing is helpful when sweat chloride tests are inconclusive and can provide a more direct assessment of CFTR functionality. Other Tests: Fecal Elastase: Used to evaluate pancreatic exocrine function, which is impaired in CF. Chest Imaging: Although not diagnostic, imaging can assess lung disease severity, showing bronchiectasis and hyperinflation common in CF patients. Transepithelial Intestinal and Rectal Biopsies: These can be used to directly evaluate CFTR function, though are generally reserved for research or challenging cases. Serum electrolytes - hyponatremic, hypokalemic, hypochloremic alkalosis is seen in CF (contraction alkalosis) Bronchoalveolar lavage (Option A) : This test can help diagnose infections or inflammatory conditions of the lungs but does not provide direct information about CFTR function, making it insufficient for CF diagnosis. Chest X-ray (Option C): A chest X-ray can reveal structural abnormalities like bronchiectasis, commonly associated with CF. However, it is not specific for CF and is generally used to assess the extent of pulmonary damage, not as a primary diagnostic tool for uncertain cases. Genetic panel including rare CFTR mutations (Option D): Expanding the genetic panel can help detect rare CFTR mutations. However, in ambiguous cases where common mutations are not identified, this may delay diagnosis. Nasal potential difference testing is often a more immediate next step to assess ion channel function.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 6,
      "question": "A newborn screening for CF shows elevated immunoreactive trypsinogen (IRT) levels. What is the next best step in the diagnostic process?",
      "options": {
        "A": "Repeat the IRT test in 6 months",
        "B": "Genetic testing for CFTR mutations",
        "C": "Chest X-ray",
        "D": "Fecal elastase levels"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Genetic testing for CFTR mutations Explanation: Elevated IRT on newborn screening warrants follow-up with genetic testing for common CFTR mutations to confirm the diagnosis of CF in neonates I . Neonatal Screening of CF: Initial IRT Screening: Elevated immunoreactive trypsinogen (IRT) in a newborn suggests pancreatic stress and is a marker for CF. Genetic Testing Follow-up: If IRT is elevated, common CFTR mutations are checked. If the child tests positive for CFTR mutations, further diagnostic confirmation is pursued. Early detection allows for prompt initiation of treatments, improving growth and reducing the frequency of pulmonary exacerbations, which can delay lung disease progression. Repeat the IRT test in 6 months (Option A) : Waiting without confirmatory testing may delay diagnosis. Chest X-ray (Option C) : Chest X-ray does not confirm CF. Fecal elastase (Option D) is used to assess pancreatic function in CF, but it is not a diagnostic test for CF in newborns with elevated IRT. Reference: https://www.ias.ac.in/article/fulltext/jbsc/049/0064 https://www.researchgate.net/publication/340652214 _Newborn_Screening_for_Cystic_Fibrosis_in_Russia_A_Catalyst_for_Improved_Care",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 7,
      "question": "Which of the following therapies directly targets the basic molecular defect in cystic fibrosis for a patient with a G551D mutation?",
      "options": {
        "A": "Pancreatic enzyme supplements",
        "B": "Lumacaftor",
        "C": "Ivacaftor",
        "D": "Hypertonic saline nebulization"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Ivacaftor Explanation: Ivacaftor is a CFTR modulator that potentiates the CFTR channel, especially in patients with G551D mutations, enhancing chloride ion transport across cell membranes I . Treatment of Cystic Fibrosis: CFTR Modulators: Target the root cause of CF in patients with specific mutations. Ivacaftor: A potentiator for gating mutations like G551D, enhancing chloride transport by improving CFTR channel opening. (Option C) Lumacaftor and Tezacaftor: Correctors that aid CFTR protein folding and trafficking, effective for F508del homozygous patients when combined with ivacaftor. Elexacaftor-Tezacaftor-Ivacaftor (Trikafta) : A triple-combination therapy approved for patients with at least one F508del mutation. This combination substantially improves lung function, nutritional status, and quality of life. Pulmonary Therapy: For improving mucus clearance and managing chronic infections. Airway Clearance Techniques (ACTs): Chest physiotherapy, high-frequency chest wall oscillation, and oscillating positive expiratory pressure (PEP) devices help mobilize and clear thick mucus. Nebulized Medications: Hypertonic saline and recombinant human DNase (dornase alfa) thin mucus and enhance clearance. Inhaled antibiotics (e.g., tobramycin) are used for chronic Pseudomonas infections. Anti-inflammatory Agents: Azithromycin is used for intense inflammation in CF lungs for its anti-inflammatory properties. Digestive Support: Pancreatic enzyme replacement therapy for managing pancreatic insufficiency. Enzyme supplements improve digestion and nutrient absorption. Fat-soluble vitamin supplementation (A, D, E, K) to prevent deficiencies. High-calorie, high-protein diet: to maintain adequate growth and body weight. CF Complications: CF-related Diabetes (CFRD): Managed with insulin, as oral hypoglycemic agents are generally ineffective. Liver Disease: Ursodeoxycholic acid can be used to manage biliary complications. End-stage Lung Disease: Lung transplantation is an option for advanced disease with respiratory failure. Median survival post-transplant is over 9 years. Pancreatic enzyme supplements (Option A) help digestion but do not address the CFTR defect. Lumacaftor (Option B) is used for F508del mutations. Hypertonic saline (Option D) aids mucus clearance but does not modify CFTR function. Reference: Harrison’s Principles Of Internal Medicine, 21st Edition, Volume I, Page 2178-2180.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 8,
      "question": "A 45-year-old obese male (BMI- 40) presents with complaints of loud snoring and daytime sleepiness. His wife reports that he complains of disturbed sleep due to waking up out of breath because of an obstruction of the airway. Polysomnography reveals repetitive episodes showing: Sharp inspiratory uptake Flattened/plateau wave Scooped out breathing pattern Flow limitation Oxygen desaturation What is the correct sequence of pathophysiologic events leading to his symptoms? → Hypoxia → Pharyngeal dilator muscle relaxation → Airway narrowing → snoring → Airway narrowing → Flow limitation → Hypoxia → Cortical arousal → Flow limitation → Airway collapse → Snoring → Bradycardia → Hypoxia → Airway collapse → Flow limitation → Bradycardia → Cortical arousal",
      "options": {
        "A": "REM sleep",
        "B": "Pharyngeal dilator muscle relaxation",
        "C": "Obesity",
        "D": "Hypoxia"
      },
      "correct_answer": "B",
      "explanation": "→ Airway narrowing → Flow limitation → Hypoxia → Cortical arousal Correct Answer: B) Pharyngeal dilator muscle relaxation → Airway narrowing → Flow limitation → Hypoxia → Cortical arousal Explanation : The pathophysiologic sequence in obstructive sleep apnea (OSA) begins with: Pharyngeal dilator muscle tone decreases during REM sleep This leads to the narrowing of the airway Flow limitation occurs, causing characteristic breathing pattern Resultant hypoxia develops Finally, cortical arousal occurs to restore airway patency Normal physiology: Pharyngeal dilator muscles maintain airway patency They prevent tongue from falling backward when supine Normal sinusoidal inspiration & expiration occurs Pathophysiologic sequence in OSA: A) Initial events: During REM sleep, muscle tone decreases Airway narrows (worse with obesity or micrognathia) Soft tissues vibrate (especially uvula) causing snoring B) Progressive changes: Flow limitation pattern develops: Sharp inspiratory uptake Flattened/plateau wave Scooped pattern Complete obstruction leads to apneic episode C) Physiologic consequences: Bradycardia (<40 bpm) SpO2 falls Cortical arousals occur Sleep interruption Grunting and forceful airway opening Sudden increase in heart rate D) Long-term effects: Left ventricular hypertrophy LV strain Secondary hypertension Increased cardiovascular mortality Extreme fatigue Never waking up fresh Continuous body pain Reference: Harrison’s Principles Of Internal Medicine, 21st Edition, Volume I, Page 2204-2208.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 9,
      "question": "A 45-year-old man presents with complaints of daytime sleepiness and morning headaches, and his wife reports loud snoring with episodes of gasping during sleep. His BMI is 32 kg/m², neck circumference is 44 cm, and he has retrognathia. His blood pressure is 148/92 mmHg. Which of the following combinations of additional clinical features and diagnostic findings would not be seen with obstructive sleep apnea in this patient?",
      "options": {
        "A": "Fragmented sleep on PSG",
        "B": "Central obesity, elevated sweat chloride, pancreatic insufficiency",
        "C": "Nondipping nocturnal blood pressure pattern",
        "D": "Frequent arousals with oxygen desaturation"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Central obesity, elevated sweat chloride, pancreatic insufficiency Explanation: Nondipping blood pressure pattern is characteristic of OSA PSG (polysomnography) showing fragmented sleep with frequent arousals is diagnostic Oxygen desaturation occurs with apneic episodes These findings match the patient's symptoms and risk factors (obesity, retrognathia) Clinical Features of Obstructive Sleep Apnea Category Clinical Features Nocturnal Symptoms Loud snoring Witnessed apneas Gasping/choking episodes Frequent awakenings Daytime Symptoms Excessive daytime sleepiness Morning headaches Difficulty concentrating Irritability Physical Findings Obesity (especially central) Large neck circumference Retrognathia Hypertension Diagnostic Findings Fragmented sleep on PSG Frequent arousals Oxygen desaturation Nondipping blood pressure pattern Polysomnography findings of Obstructive sleep apnea PSG Parameter Typical OSA Findings Clinical Significance Respiratory Events Cessation of airflow ≥ 10 seconds Continued chest/abdominal effort AHI 5-14 (mild), 15-29 (moderate), ≥ 30 (severe) Indicates upper airway obstruction with continued respiratory effort Oxygen Saturation Intermittent desaturations ≥ 3% Cycling pattern with events May see significant drops Reflects severity and potential cardiovascular impact Sleep Architecture Increased light sleep (N1) Reduced deep sleep (N3) Reduced REM sleep Fragmented sleep pattern Indicates sleep disruption and poor sleep quality Arousals Frequent cortical arousals Event-related arousals Increased arousal index Leads to sleep fragmentation and daytime symptoms Central obesity, elevated sweat chloride, pancreatic insufficiency (Option B): Elevated sweat chloride and pancreatic insufficiency are hallmark features of cystic fibrosis, not OSA. Central obesity is seen in both CF and OSA but is not specific to either condition alone. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Volume I, Page. 2206, 2207",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 10,
      "question": "Which of the following statements is incorrect regarding risk factors of Obstructive Sleep Apnea?",
      "options": {
        "A": "Premenopausal women have the same risk for OSA as postmenopausal women",
        "B": "A 10% increase in body weight is associated with a >30% increase in apnea-hypopnea index (AHI)",
        "C": "Approximately 40-60% of OSA cases are attributable to excess body weight",
        "D": "Men have approximately twice the risk of developing OSA compared to women"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Premenopausal women have the same risk for OSA as postmenopausal women. premenopausal women Loss of hormonal protection contributes to increased OSA risk Risk factors for Obstructive sleep apnea Category Risk Factors Clinical Impact Demographic Male gender Older age Post-menopausal status Family history Men have 2x higher risk (Option D) Risk increases with age Hormonal protection in premenopausal women Anatomical Retrognathia/micrognathia Increased neck circumference (>40cm in women, >43cm in men) Nasal obstruction Enlarged tonsils Affects airway patency Increases collapsibility Reduces airway diameter Body Composition Obesity (BMI >30) Central adiposity Weight gain Large waist circumference 40-60% of OSA attributable to excess weight (Option C) 10% weight gain increases AHI by >30% (Option B) Medical Conditions Endocrine disorders (hypothyroidism, acromegaly) Diabetes mellitus Hypertension Down syndrome Increases susceptibility May affect treatment response Bidirectional relationship Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Volume I, Page. 2205, 2206",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 11,
      "question": "A 52-year-old man presents to his primary care physician with complaints of excessive daytime sleepiness and his spouse reports loud snoring with disturbed sleep due to breathing pauses during sleep. His BMI is 34 kg/m² and neck circumference is 43 cm. Which of the following should be the INITIAL step in evaluating this patient? physical examination",
      "options": {
        "A": "Order an overnight polysomnography immediately",
        "B": "Start CPAP therapy based on symptoms",
        "C": "Obtain detailed sleep history with standardized sleepiness questionnaires and perform focused",
        "D": "Order overnight home oximetry"
      },
      "correct_answer": "C",
      "explanation": "perform focused physical examination Correct Answer: C) Obtain detailed sleep history with standardized sleepiness questionnaires and perform focused physical examination Explanation: Initial evaluation for OSA should include comprehensive sleep history, standardized assessments (Epworth Sleepiness Scale, STOP-BANG questionnaire) and physical examination such as BMI and neck circumference , upper airway assessment, etc. Workup and Investigations for Obstructive sleep apnea Diagnostic Step Key Components Clinical Significance Initial Evaluation Detailed sleep history Bed partner history Epworth Sleepiness Scale Screening questionnaires Assess symptom severity Document witnessed events Quantify daytime sleepiness Screen for risk factors Physical Examination BMI and neck circumference Upper airway examination Jaw structure assessment Nasal examination Cardiovascular evaluation Identify anatomic risk factors Assess for complications Guide treatment options Screen for comorbidities Sleep Study Options In-lab polysomnography (PSG) Home sleep testing (HST) Split-night study if indicated Gold standard & IOC : PSG HST for selected patients Quantify disease severity Guide treatment decisions Additional Testing ECG/cardiac evaluation Blood pressure monitoring Metabolic screening Cognitive/alertness testing Assess complications Monitor comorbidities Guide comprehensive management Evaluate impairment Polysomnography shouldn't be ordered without proper initial evaluation and documentation of symptoms/signs ( Option A) CPAP therapy requires objective diagnosis and proper titration; cannot be started empirically ( Option B) Oximetry alone is inadequate as initial testing and should not be ordered before proper clinical evaluation ( Option D) Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Volume I, Page. 2205, 2206, 2207",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 12,
      "question": "A 45-year-old man is diagnosed with moderate obstructive sleep apnea (AHI=22/hour) based on polysomnography. He has daytime sleepiness, BMI of 35 kg/m², and hypertension. Which of the following is the most appropriate initial treatment approach for this patient?",
      "options": {
        "A": "Prescribe oral appliance therapy as first-line treatment",
        "B": "Initiate CPAP therapy with appropriate pressure titration and provide supportive care",
        "C": "Recommend uvulopalatopharyngoplasty without trying conservative measures",
        "D": "Lifestyle modification and weight loss"
      },
      "correct_answer": "B",
      "explanation": "supportive care Correct Answer: B) Initiate CPAP therapy with appropriate pressure titration and provide supportive care Explanation: Initiating CPAP is the treatment of choice in this patient because: CPAP is the gold standard first-line therapy Appropriate for moderate OSA Most effective in improving: AHI (Apnea Hypoapnea index) Daytime sleepiness Blood pressure Quality of life Treatment of Obstructive sleep apnea Treatment Option Indications/Features Advantages/Limitations CPAP Therapy First-line therapy & Gold standard All severity levels Requires titration study Regular monitoring needed Most effective option Reversible/non-invasive Insurance covered Adherence challenges Lifestyle Modifications and weight loss (Option D) Weight loss Sleep position therapy Alcohol avoidance Sleep hygiene Adjunctive to primary therapy Long-term benefits No immediate relief Variable results Oral Appliances (Option A) Mild to moderate OSA CPAP intolerance Good dental health Normal TMJ More comfortable than CPAP Portable Less effective than CPAP Dental side effects Surgical Options (Option C) Specific anatomic defects Failed conservative therapy Carefully selected patients Bariatric surgery for obesity Permanent solution No ongoing compliance needed Invasive Variable success rates Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Volume I, Page. 2208, 2209",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 13,
      "question": "A 45-year-old male reports persistent daytime sleepiness, often dozing off during meetings and while watching television. He completes the Epworth Sleepiness Scale (ESS) and scores 12. What does a score of 12 indicate?",
      "options": {
        "A": "Unlikely to be abnormally sleepy.",
        "B": "Average daytime sleepiness.",
        "C": "Possibly excessively sleepy; consider medical attention.",
        "D": "Excessively sleepy; seek immediate medical attention."
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Possibly excessively sleepy; consider medical attention. Explanation: A score of 10-15 on the Epworth Sleepiness Scale indicates that the individual may be experiencing excessive sleepiness, depending on the context. This suggests a potential need for further evaluation to rule out underlying conditions, such as sleep disorders. Epworth Sleepiness Scale: The Epworth Sleepiness Scale (ESS) assesses daytime sleepiness, with a score of 10 or higher indicating the need for further evaluation. However, it is not an effective tool for screening sleep-disordered breathing. The test consists of eight situations where you rate your tendency to feel sleepy. It helps assess whether you may be experiencing excessive sleepiness that could require medical evaluation. Situation No Chance (0) Slight Chance (1) Moderate Chance (2) High Chance (3) Sitting and reading No chance of dozing = 0 Slight chance of dozing = 1 Moderate chance of dozing = 2 High chance of dozing = 3 Watching television Sitting inactive in a public space Lying down to rest in the afternoon when permitted Sitting and talking to someone Sitting quietly after lunch without alcohol As a passenger in a car for an hour without a break In a car, while stopped for a few minutes in traffic Total Score: 0 to 24 Interpretation: 0-7 : Unlikely to be abnormally sleepy. (Option A) 8-9 : Average daytime sleepiness. (Option B) 10-15 : Possibly excessively sleepy; consider medical attention. 16-24 : Excessively sleepy; seek medical attention. (Option D) Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2203 nasemso.org/wp-content/uploads/neuro-epworthsleepscale.pdf www.cdc.gov/niosh/work-hour-training-for-nurses/longhours/mod2/09.html",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 14,
      "question": "A 52-year-old obese male presents to the clinic with excessive daytime sleepiness hypoventilation and difficulty breathing at night. His BMI is 32 kg/m², and arterial blood gas analysis shows a Paco2 of 48 mmHg recorded during the day. The patient reports loud snoring and episodes of gasping during sleep. He has a history of severe obesity and is suspected of having obstructive sleep apnea. Based on the scenario, which of the following diagnoses is most likely?",
      "options": {
        "A": "Central Hypoventilation Syndrome",
        "B": "Obesity Hypoventilation Syndrome",
        "C": "Congenital Central Hypoventilation Syndrome",
        "D": "Simple Obstructive Sleep Apnea"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Obesity Hypoventilation Syndrome Explanation: The patient’s BMI of 32 kg/m², chronic daytime hypoventilation (Paco2 ≥ 45 mmHg), and evidence of sleep-disordered breathing (loud snoring and gasping) are consistent with Obesity Hypoventilation Syndrome. Obesity Hypoventilation Syndrome (OHS) Diagnosis requires BMI ≥ 30 kg/m² Chronic daytime alveolar hypoventilation (Paco2 ≥ 45 mmHg) and Evidence of sleep-disordered breathing, mostly obstructive sleep apnea (OSA). Risk factors- Severe obesity (BMI >40 kg/m²) and severe OSA (AHI >30 events per hour). Pathogenesis involves OSA, increased work of breathing, respiratory muscle impairment, ventilation-perfusion mismatch, and depressed central ventilatory responsiveness. Treatment: Substantial weight loss (20–25% of body weight) can normalize Paco2. CPAP improves daytime hypercapnia in over half of OHS patients with severe OSA. NIPPV is recommended if hypercapnia persists after CPAP therapy, especially in patients with acute decompensated OHS. Comorbid conditions that impair ventilation, such as COPD, should be treated alongside OHS. Central Hypoventilation Syndrome (Option A & C ruled out) Can occur later in life or in neonates as Ondine’s curse or congenital central hypoventilation syndrome (CCHS). Caused by abnormalities in the PHOX2b gene , affecting neuronal development. Patients exhibit absent respiratory response to hypoxia/hypercapnia and mildly elevated PaCO2 while awake. Markedly elevated PaCO2 occurs during non-REM sleep; ventilation normalizes during exercise and REM sleep. Treatment: NIPPV or mechanical ventilation Phrenic nerve or diaphragmatic pacing may be considered in specialized centers. Simple Obstructive Sleep Apnea (Option D): While the patient shows symptoms consistent with obstructive sleep apnea (OSA), the presence of daytime hypoventilation (elevated Paco2) indicates a more severe condition i.e Obesity Hypoventilation Syndrome, which includes OSA as a component. Simple OSA alone does not cause sustained hypercapnia. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2203, 2204",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 15,
      "question": "A 25-year-old tall male presents to the emergency department with acute retrosternal chest pain and difficulty breathing after a vigorous bout of coughing. He reports having experienced frequent coughing spells over the past week due to a respiratory infection. On physical examination, subcutaneous emphysema is noted in the neck region. The chest X-ray of the patient is given below. Which of the following statements best describes a potential cause of this patient’s condition?",
      "options": {
        "A": "The condition is likely caused by a foreign body in the airway.",
        "B": "Increased intra-alveolar pressure from excessive coughing can lead to alveolar rupture.",
        "C": "This condition is primarily associated with high BMI individuals.",
        "D": "Always a result of blunt trauma."
      },
      "correct_answer": "B",
      "explanation": "rupture. Correct Answer: B) Increased intra-alveolar pressure from excessive coughing can lead to alveolar rupture. Explanation: The diagnosis of pneumomediastinum is supported by the patient's acute chest pain and difficulty breathing after vigorous coughing, leading to increased intra-alveolar pressure and potential alveolar rupture. Chest X-ray findings shows air outlining the mediastinal structures, along with subcutaneous emphysema, confirming the condition. Excessive coughing can increase intra-alveolar pressure, potentially leading to alveolar rupture and the development of pneumomediastinum. Pneumomediastinum About Air in the mediastinum (mediastinal emphysema). Air can extravasate from airways, lungs, or esophagus into the mediastinal space and may dissect into cervical subcutaneous tissues, epidural space, pericardium, or peritoneal cavity. Most common in younger males of tall stature with low BMI. Pneumomediastinum is rare and usually self-limited Etiology",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Pulmonology-Cystic_Fibrosis_Obstructive_Sleep_Apnea_Q15_q.png",
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    },
    {
      "q_no": 16,
      "question": "A 7-year-old boy presents to the emergency department with chest pain and difficulty breathing after experiencing a severe coughing fit. A chest X-ray is performed and is given below. Which of the following statements is true regarding the management of this condition?",
      "options": {
        "A": "The primary diagnostic tool for this condition is a CT scan.",
        "B": "Surgical intervention is always required for treatment.",
        "C": "Conservative management is usually sufficient for most patients with this condition.",
        "D": "Prophylactic antibiotics are necessary for all patients diagnosed."
      },
      "correct_answer": "C",
      "explanation": "condition. Correct Answer: C) Conservative management is usually sufficient for most patients with this condition. Explanation: In this scenario, the 7-year-old boy presents with chest pain and difficulty breathing following a severe coughing fit. The chest X-ray reveals air outlining the mediastinal structures, which is characteristic of pneumomediastinum. Most cases of pneumomediastinum in pediatric patients are self-limited and can be managed conservatively with symptomatic treatment. Diagnosis of Pneumomediastinum Chest X-ray: Primary diagnostic tool typically used to diagnose pneumomediastinum, with the most common finding being air outlining mediastinal structures (90% of cases). (Option A) Subcutaneous emphysema. Elevation of the thymus in pediatric patients ( spinnaker sign ). Air surrounding the pulmonary arteries ( ring sign ). Naclerio V sign secondary to esophageal rupture- Hyperlucent \"V\" shape between descending aorta and left hemidiaphragm. Double bronchial wall. Continuous diaphragm sign. Pleural effusion (suggestive of esophageal injury). CT scan: Used if chest X-ray findings are unclear, allowing detection of small air amounts, differentiation from",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Pulmonology-Cystic_Fibrosis_Obstructive_Sleep_Apnea_Q16_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Pulmonology-Cystic Fibrosis Obstructive Sleep Apnea"
    }
  ]
}
